Position in JNJ
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$5,236,861
-$370,348 QoQ
Shares Held
20,620
-10.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#1,589
of 4,676 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BDF-GESTION holds $47,173,274 across 6 Drug Manufacturers - General names. JNJ ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,034 | $21,630,522 | |
| 2 | ABBV |
AbbVie Inc.
|
40,006 | $10,067,109 | |
| 3 | MRK |
Merck & Co., Inc.
|
42,451 | $5,454,953 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
20,620 | $5,236,861 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,801 | $2,754,338 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,222 | $2,029,491 |
All Filings in JNJ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,236,861 | 20,620 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $5,607,209 | 22,939 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $4,747,226 | 22,939 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $4,536,856 | 24,468 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $4,514,679 | 29,556 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $5,435,737 | 32,777 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $4,740,209 | 32,777 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $6,001,892 | 37,035 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $5,413,035 | 37,035 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||